ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

NIVOLUMABUM

Active substance (INN) · ATC L01FF01 · 4 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L01FF-L01EX	NIVOLUMABUM + DCI CABOZANTINIBUM	In force	medicine of the protocol	C2-P3	NO
L01XC11-17	NIVOLUMABUM + DCI IPILIMUMABUM	In force	medicine of the protocol	C2-P3	NO
L01XC17	NIVOLUMABUM	In force	medicine of the protocol	C2-P3	NO
L01XC31	AVELUMABUM	In force	mentioned in the text	C2-P3	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
OPDIVO 10 mg/ml	CONC. PT. SOL. PERF.	10mg/ml	BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA	L01FF01	PR
OPDIVO 300 mg	SOL. INJ.	300mg	BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA	L01FF01	PR
OPDIVO 600 mg	SOL. INJ.	600mg	BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA	L01FF01	PR
OPDUALAG 240 mg/80 mg	CONC. PT. SOL. PERF.	240mg/80mg	BRISTOL MYERS SQUIBB PHARMA EEIG - IRLANDA	L01FY02	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.